AVR 0.73% $15.04 anteris technologies ltd

Admedus Immunotherapy Deal

  1. 3,092 Posts.
    lightbulb Created with Sketch. 69
    Thank you to the Good Doctor who originally posted this.

    "Mr Paterson says he will “know either way” by the end of March if the company (ASX:AHZ) has a partner that will take the lead financially for the drug development business."

    https://unauthorised investment advice/health/med...r-profit-after-near-death-experience-says-ceo

    Very very exciting. The funds this could attract will be put to brilliant use accelerating the sale of the company's ADAPT products across the world and also in the development of our 3D vascular patch (which I believe will be used in surgeries for the femoral artery...)
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.04
Change
-0.110(0.73%)
Mkt cap ! $292.1M
Open High Low Value Volume
$15.35 $15.35 $15.00 $53.31K 3.509K

Buyers (Bids)

No. Vol. Price($)
1 43 $15.04
 

Sellers (Offers)

Price($) Vol. No.
$15.18 182 3
View Market Depth
Last trade - 13.10pm 31/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.